ADORA2A and Hepatic fibrosis: Thus, it is of potential interest to elucidate the mechanisms behind the antifibrogenic effects of the α2-AR blockade in general and to explore the potential therapeutic value of the novel α2-adrenoblocker mesedin in liver fibrosis/cirrhosis in particular.